Healthcare News
 Updated 3 times daily.
 Select a news topic:
Kaj Blennow's Pioneering Research Into Alzheimer's Disease Recognised By The 2010 ECNP Neuropsychopharmacology Award Wed, 08 Sep 2010
The European College of Neuropsychopharmacology (ECNP) is pleased to announce Kaj Blennow as the recipient of the 2010 ECNP Neuropsychopharmacology Award in recognition of his original and influential contributions to Alzheimer's disease research...
Yeast Holds Clues To Parkinson's Disease Wed, 08 Sep 2010
Yeast could be a powerful ally in the discovery of new therapeutic drugs to treat Parkinson's disease says a scientist presenting his work at the Society for General Microbiology's autumn meeting in Nottingham today...
Researchers Identify New Therapeutic Target To Improve Pain Management After Chronic Morphine Administration Wed, 08 Sep 2010
Researchers from Mount Sinai School of Medicine have discovered a major mechanism underlying the development of tolerance to chronic morphine treatment. The discovery may help researchers find new therapies to treat chronic pain, and reduce tolerance and side effects associated with morphine use. The findings are published in the July 20th issue of Science Signaling...
Mild Cognitive Impairment Is More Common In Men Wed, 08 Sep 2010
A new Mayo Clinic study found that the prevalence of mild cognitive impairment was 1.5 times higher in men than in women. The research, part of the Mayo Clinic Study of Aging, also showed a prevalence rate of 16 percent in the population-based study of individuals aged 70-89 without dementia who live in Olmsted County, Minn. The study will be published in the September issue of Neurology...
K2M Receives 510(k) Clearance For Its CHESAPEAKE Anterior-Lumbar Stabilization System Wed, 08 Sep 2010
K2M, Inc., a spinal device company developing innovative solutions for the treatment of complex spinal pathologies, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its new CHESAPEAKE? Anterior-Lumbar Stabilization System, a unique interbody device designed for stabilization of the spine through an anterior approach...
Brain Function, Task Performance In Cocaine Abusers, Improved By Ritalin Wed, 08 Sep 2010
A brain-scanning study at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory, conducted with collaborators from Stony Brook University, reveals that an oral dose of methylphenidate, commonly known as Ritalin, improves impaired brain function and enhances cognitive performance in people who are addicted to cocaine...
Association Between Inflammation, Lower Intelligence And Premature Death Wed, 08 Sep 2010
Inflammation is associated with lower intelligence and premature death, according to Swedish scientists from the Karolinska Institute in Stockholm, Sweden. "Those with low-grade inflammation performed more poorly on standardised intelligence tests, even after excluding those with signs of current illness...
Memory Problems Or Mild Cognitive Impairment More Common In Men Tue, 07 Sep 2010
Mild cognitive impairment, which may include problems with memory or thinking beyond that explained by the normal aging rate, is more common among men than women, say researchers in an article published in the medical journal Neurology, September 7 issue...
Memory Problems More Common In Men? Tue, 07 Sep 2010
A new study shows that mild cognitive impairment (MCI) may affect more men than women. The research is published in the September 7, 2010, print issue of Neurology®, the medical journal of the American Academy of Neurology. Mild cognitive impairment is a condition in which people have problems with memory or thinking beyond that explained by the normal rate of aging...
Scientists Decode Words From Brain Signals Tue, 07 Sep 2010
In an early step toward letting severely paralyzed people speak with their thoughts, University of Utah researchers translated brain signals into words using two grids of 16 microelectrodes implanted beneath the skull but atop the brain...
Men Are More Likely To Develop Mild Cognitive Impairment Than Women - Alzheimer's Society Comment Tue, 07 Sep 2010
Mild cognitive impairment (MCI) may affect more men than women research published in the journal Neurology claims. The study of 2,050 people aged 70-89 living in Olmstead County, Minnesota found MCI was 1.5 times higher in men than women with 19 percent of men having MCI compared to 14 percent of women...
New Model May Simplify High-Dose Radiosurgery Planning Mon, 06 Sep 2010
There is yet no straightforward way to determine the optimal dose level and treatment schedules for high-dose radiation therapies such as stereotactic radiation therapy, which is used to treat brain and lung cancer, or for high-dose brachytherapy for prostate and other cancers. Radiation oncologists at the Ohio State University Comprehensive Cancer Center-Arthur G...
Reports Of Narcolepsy In Europe Following Vaccination With Pandemrix? Sun, 05 Sep 2010
GSK initially became aware of possible cases of narcolepsy following vaccination with the adjuvanted H1N1 pandemic vaccine Pandemrix through adverse event reports received by the Swedish Medical Products Agency, and subsequently via media reports in Finland...
BioDelivery Sciences Announces Positive Meeting With FDA On A Streamlined ONSOLIS REMS With Broadened Distribution Sun, 05 Sep 2010
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) announced a positive meeting with the U.S. Food and Drug Administration (FDA), Meda and BDSI that occurred on Wednesday, July 21, 2010 to discuss significant modifications to the existing Risk Evaluation and Mitigation Strategy (REMS) program for ONSOLIS (fentanyl buccal soluble film)...
U.S. Neurologists Agree On Protocols For Treatment Of Infantile Spasms Sat, 04 Sep 2010
Researchers from across the U.S., as part of the Infantile Spasms Working Group (ISWG), established guidelines for the diagnosis and treatment of infantile spasms (IS). The goal of the ISWG is to improve patient outcomes by creating protocols that educate pediatricians on early diagnosis and treatment options...
All Genes In One Go Sat, 04 Sep 2010
The majority of rare diseases are hereditary. But despite significant progress in genome research, in most cases their exact cause remains unclear. The discovery of the underlying genetic defect is, however, a prerequisite for their definitive diagnosis and the development of innovative approaches to their treatment...
Rochester Leads International Effort To Improve Muscular Dystrophy Treatment Sat, 04 Sep 2010
A large international study aimed at improving the care of muscular dystrophy patients worldwide is being launched by physicians, physical therapists, and researchers at the University of Rochester Medical Center. Neurologist Robert "Berch" Griggs, M.D., is heading the study of treatments for Duchenne muscular dystrophy, the most common form of the disease that affects children...
What's Causing Life-Threatening Blood Clots Following Brain Surgery? Sat, 04 Sep 2010
One of the most severe complications of brain surgery is a life-threatening blood clot in the lungs called a pulmonary embolism. But a Loyola University Health System study published in the Journal of Neurosurgery suggests that screening methods hospitals typically use to access the risk of pulmonary embolisms may fall short...
Functional Motor Neuron Subtypes Generated From Embryonic Stem Cells Sat, 04 Sep 2010
Scientists have devised a method for coaxing mouse embryonic stem cells into forming a highly specific motor neuron subtype. The research, published by Cell Press in the September 3rd issue of the journal Cell Stem Cell, provides new insight into motor neuron differentiation and may prove useful for devising and testing future therapies for motor neuron diseases...
Scientists Uncover Counterpart Of Cerebral Cortex In Marine Worms Sat, 04 Sep 2010
Our cerebral cortex, or pallium, is a big part of what makes us human: art, literature and science would not exist had this most fascinating part of our brain not emerged in some less intelligent ancestor in prehistoric times...
Moussa B.H. Youdim Wins The 2010 ECNP Lifetime Achievement Award Fri, 03 Sep 2010
Award presentation at the 23rd Congress of the European College of Neuropsychopharmacology in Amsterdam, The Netherlands The European College of Neuropsychopharmacology (ECNP) is pleased to announce Moussa B. H...
Cancer Drug Model Could Be A Potential Treatment For Alzheimer's - Alzheimer's Society Comment Fri, 03 Sep 2010
Treatments modelled on the cancer drug Gleevec could potentially prevent the formation of amyloid plaques - one of the major hallmarks of Alzheimer's disease according to a study. Treatments modelled on the cancer drug Gleevec could potentially prevent the formation of amyloid plaques - one of the major hallmarks of Alzheimer's disease according to a study published in the journal Nature...
Most Neurologists Plan To Prescribe Oral Multiple Sclerosis Drugs, But Will Proceed With Caution Fri, 03 Sep 2010
In a study published this week by Majestic Research, almost 60% of neurologists expressed unaided concern about the side effects/safety of oral MS therapies in development, including NVS's Gilenia and MRK/EMD Serono's oral cladribine...
In A Rat Model Of Stroke, Protecting Nerve Cells From Death Fri, 03 Sep 2010
A team of researchers, led by Yizheng Wang, at the Chinese Academy of Sciences, China, has identified a way to preserve nerve cells in a rat model of stroke. Stroke is most commonly caused by impaired delivery of oxygen to part of the brain as a result of disruption to the blood supply (a condition known as ischemia)...
Eisai Announces The Start Of The First Clinical Study Of Ban2401, A Novel Monoclonal Antibody Targeting Neurotoxic Protofibrils Thu, 02 Sep 2010
Eisai Co., Ltd. (Headquarters: Tokyo, Japan, President & CEO: Haruo Naito, "Eisai") announced today the start of the first patient enrolled clinical study with BAN2401, a novel monoclonal antibody that is being developed as a potential next-generation therapeutic treatment for Alzheimer's disease...
Copyright © 1998-2006 Silver Oak Search Consultants, Inc. All Rights Reserved.